Photo of Eric B. Suhler, M.D., M.P.H.

Eric B. Suhler M.D., M.P.H.

After completing his training in ophthalmology at the Casey Eye Institute in 2000, Dr. Suhler received an additional two years of training in uveitis clinical care and research at the National Eye Institute of the National Institutes of Health in Bethesda, Maryland from 2000 to 2002, and completed a Masters in Public Health from OHSU in 2007. 

He is co-director of the OHSU Uveitis Clinic, where he sees patients on referral from eye care providers throughout the Pacific Northwest. He is active in clinical research and clinical trials utilizing cutting edge immunotherapeutic drugs for the treatment of ocular inflammatory diseases and has regularly presented the results of these trials at national and international research meetings. Dr. Suhler also directs the Casey Uveitis Fellowship.

Dr. Suhler is also chief of ophthalmology at the Portland Veterans Administration Medical Center. He received his undergraduate education at Southern Methodist University in Dallas, Texas, and attended medical school at the University of Texas Southwestern Medical Center in Dallas.

Read more

Education

  • M.D., University of Texas, Southwestern Medical Center, Dallas Texas 1995
  • M.P.H., Oregon Health and Science University, Portland Oregon 2007
  • Residency:

    • Ophthalmology: OHSU, 2000
  • Fellowship:

    • Uveitis and clinical ocular immunology: NIH, 2002
  • Certifications:

    • Ophthalmology

Publications

  • "In Vivo Laser Confocal Microscopy Using the HRT-Rostock Cornea Module : Diversity and Diagnostic Implications in Patients with Uveitis." Ocular Immunology and Inflammation  In: , 28.05.2017, p. 1-10.
  • "Risk of Ocular Hypertension in Adults with Noninfectious Uveitis." Ophthalmology In: , 01.12.2016.
  • "Prevalence of noninfectious uveitis in the United States : A claims-based analysis." JAMA Ophthalmology  In: , Vol. 134, No. 11, 01.11.2016, p. 1237-1245.
  • "Adalimumab in patients with active noninfectious uveitis." New England Journal of Medicine In: , Vol. 375, No. 10, 08.09.2016, p. 932-943.
  • "Review for Disease of the Year : Epidemiology of HLA-B27 Associated Ocular Disorders." Ocular Immunology and Inflammation In: , 28.05.2016, p. 1-6.
  • "Parafoveal cone abnormalities and recovery on adaptive optics in posterior uveitis." American Journal of Ophthalmology Case Reports  In: , Vol. 1, 01.04.2016, p. 16-22.
  • "Remission of Intermediate Uveitis : Incidence and Predictive Factors." American journal of ophthalmology  In: , Vol. 164, 01.04.2016, p. 110-117.
  • "Adalimumab for Ocular Inflammation." Ocular Immunology and Inflammation  In: , 21.03.2016, p. 1-8.
  • "Risk of retinal neovascularization in cases of uveitis." Ophthalmology In: , Vol. 123, No. 3, 01.03.2016, p. 646-654.
  • "Methotrexate."   Intraocular Inflammation. Springer Berlin Heidelberg, 2016. p. 355-361.
  • "Granulomatosis with Polyangiitis (Gpa) Presenting with Frosted Branch Angiitis." Retinal Cases and Brief Reports In: , Vol. 10, No. 3, 2016, p. 249-251.
  • "The risk of intraocular pressure elevation in pediatric noninfectious uveitis." Ophthalmology In: , Vol. 122, No. 10, 01.10.2015, p. 1987-2001.
  • "Peripheral vascular leakage in uveitis : Clinical and angiographic findings." Ophthalmology  In: , Vol. 122, No. 6, 01.06.2015, p. 1269-1270.
  • "Drug-induced uveitis." International Ophthalmology Clinics In: , Vol. 55, No. 2, 09.04.2015, p. 47-65.
  • "Biological response modifiers in the treatment of noninfectious Uveitis." International Ophthalmology Clinics  In: , Vol. 55, No. 2, 09.04.2015, p. 19-36.
  • "Retinal detachment associated with ocular toxoplasmosis." Retina In: , Vol. 35, No. 2, 06.02.2015, p. 358-363.
  • "Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists." Ocular Immunology and Inflammation  In: , Vol. 23, No. 1, 01.02.2015, p. 25-31.
  • "Characterisation of uveitis in association with multiple sclerosis." British Journal of Ophthalmology In: , Vol. 99, No. 2, 01.02.2015, p. 205-209.
  • "Aqueous cell differentiation in anterior uveitis using fourier-domain optical coherence tomography." Investigative Ophthalmology and Visual Science  In: , Vol. 56, No. 3, 2015, p. 1430-1436.
  • "Periocular corticosteroid injections in uveitis : Effects and complications." Ophthalmology In: , Vol. 121, No. 11, 01.11.2014, p. 2275-2286.
  • "Rituximab therapy for refractory scleritis : Results of a phase I/II dose-ranging, randomized, clinical trial." Ophthalmology In: , Vol. 121, No. 10, 01.10.2014, p. 1885-1891.
  • "Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome." Ophthalmic Surgery Lasers and Imaging Retina In: , Vol. 45, No. 5, 01.09.2014, p. 399-407.
  • "Factors predictive of remission of new-onset anterior uveitis." Ophthalmology In: , Vol. 121, No. 3, 03.2014, p. 778-784.
  • "Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema." Ophthalmology In: , Vol. 121, No. 2, 02.2014.
  • "The future of uveitis treatment." Ophthalmology In: , Vol. 121, No. 1, 01.2014, p. 365-376.
  • "Rituximab therapy for refractory orbital inflammation results of a phase 1/2, dose-ranging, randomized clinical trial." JAMA Ophthalmology In: , Vol. 132, No. 5, 2014, p. 572-578.
  • "Implications of the pacific ocular inflammation uveitis epidemiology study." JAMA - Journal of the American Medical Association In: , Vol. 311, No. 18, 2014, p. 1912-1913.
  • "The course of retinal vasculitis." British Journal of Ophthalmology In: , Vol. 98, No. 6, 2014, p. 785-789.
  • "The use of vascular endothelial growth factor inhibitor for choroidal neovascularization complicating posterior uveitis in eyes with fluocinolone acetonide implants." Retinal Cases and Brief Reports In: , Vol. 7, No. 1, 12.2013, p. 35-40.
  • "Risk of choroidal neovascularization among the uveitides." American Journal of Ophthalmology In: , Vol. 156, No. 3, 09.2013.

Additional information

Edit profile